Endo International plc, a specialty pharmaceutical company, has announced changes to its executive leadership and senior management team. Under the new management structure, Endo's US branded pharmaceuticals and US generics business units, as well ... Individual.com, 2 weeks ago
DUBLIN , Nov. 20, 2014 /PRNewswire/ --Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced that its Qualitest subsidiary has launched a generic version of Hoffmann-La Roche, Inc.'s Valcyte ® (Valganciclovir Tablets USP, 450 mg). "We ...ClinicSpace, 2 months ago Generic versions of Valcyte and Activella hit the US market Pharma Letter, 2 months ago Endo Announces Launch of Generic Version of Valcyte® Reliance Trust, 2 months ago Endo International plc Announces Launch Of Generic Version Of Valcyte BioSpace, 2 months ago
A federal judge tossed out a liability lawsuit filed against brandmakers Wyeth and Alaven Pharmaceuticals, saying they were not responsible for the death of a patient who took generic Reglan not made by the companies. The judge, from the Northern ...FDA News, 5 days ago
Devices The Siemens Symbia S series is intended for use by appropriately trained health care professionals to aid in detecting, localizing, diagnosing, staging and restaging of lesions, tumors, disease and organ function for the evaluation ...U.S. Food and Drug Administration, 2 weeks ago
Highlights of Glenview Capital's third quarter 13F filing (Part 8 of 10) ( Continued from Part 7 ) Glenview Capital and Endo International Glenview Capital Management added to its position inEndo International Plc (ENDP) in the third quarter.Yahoo! Finance, 4 weeks ago
on your WebpageAdd Widget >Get your members hooked!